- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Institute of Rheumatology, Prague가 후원하는 임상 시험
총 331 건
-
Institute of Rheumatology, PragueKarolinska Institutet완전한
-
Karolinska InstitutetKing's College Hospital NHS Trust; Institute of Rheumatology, Prague완전한
-
Institute of Rheumatology, PragueCharles University, Czech Republic; Palacky University; Ministry of Health, Czech Republic; Department of Rheumatology, Hospital, Ceske Budejovice, Czech Republic 그리고 다른 협력자들완전한
-
General University Hospital, PragueCharles University, Czech Republic; Institute of Hematology and Blood Transfusion, Czech...모병
-
Ruth Tachezy, PhD.Na Homolce Hospital; Medical Healthcom Prague완전한
-
Chinese Society of HematologyHarbin Institute of Hematology & Oncology알려지지 않은골수이형성 증후군(MDS)
-
AeskuLab Pathology PragueInstitute of Biostatistics and analyses, Ltd.완전한
-
Institute for the Care of Mother and Child, Prague...General University Hospital, Prague; Bulovka Hospital아직 모집하지 않음애셔만 증후군 | 낙태 후기
-
Federal State Budgetary Scientific Institution,...The League of Clinical Research, Russia; Institute of Biomedical Chemistry, Russia완전한
-
National Institute of Geriatrics, Rheumatology...아직 모집하지 않음수술 절차, 불특정 | 대퇴골 골절 | 엉덩이 관절염 | 이형성; 잘 알고 있기 | 무균 괴사
-
National Institute of Geriatrics, Rheumatology...완전한
-
V.A. Nasonova Research Institute of Rheumatology...AstraZeneca아직 모집하지 않음SLE 환자에서 IFN 유형 I의 상승된 수준
-
AbbottAlmedis; Scientific Research Institute of Rheumatology, Moscow완전한류마티스 관절염 | 건선성 관절염 | 강직성 척추염러시아 연방
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음HID-HSCT 후 노인 환자의 aGVHD 예방에서 인간화 CD25 항체의 효능 및 안전성
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음최소 잔류 질병 | 골수 이식 | Ph+ 모두중국
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음급성 골수성 백혈병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital모병
-
Institute of Hematology & Blood Diseases Hospital완전한
-
Institute of Hematology & Blood Diseases Hospital종료됨
-
Institute of Hematology & Blood Diseases Hospital완전한Acute,Leukemia, Lymphoid중국
-
Institute of Hematology & Blood Diseases Hospital알려지지 않은
-
Institute of Hematology & Blood Diseases Hospital완전한
-
Institute of Hematology & Blood Diseases Hospital알려지지 않은
-
Institute of Hematology & Blood Diseases Hospital알려지지 않은
-
Institute of Hematology & Blood Diseases Hospital알려지지 않은
-
Institute of Hematology & Blood Diseases Hospital알려지지 않은배뇨 장애 | 혈전증 | 단백뇨 | 빈혈, 용혈 | 혈색소뇨증, 발작성 | 혈색소뇨증 | 발작성 야간혈색소뇨증 | 골수 부전 | 재생 불량성 빈혈,중국
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음조혈모세포이식 AA 수혜자에서 aGVHD에 대한 Ruxolitinib의 예방적 가치
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음이식 후 24주 이내에 말초혈액 CMV 활성화 발생 및 임상적으로 유의한 CMV 감염 확인
-
Institute of Hematology & Blood Diseases Hospital아직 모집하지 않음CMV 재활성화 2차 예방의 효능 및 안전성 평가
-
Institute of Hematology & Blood Diseases Hospital모병코로나바이러스감염증-19 : 코로나19 | 조혈모세포이식중국
-
Institute of Hematology & Blood Diseases Hospital모병